ATE237360T1 - Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation - Google Patents

Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation

Info

Publication number
ATE237360T1
ATE237360T1 AT98940480T AT98940480T ATE237360T1 AT E237360 T1 ATE237360 T1 AT E237360T1 AT 98940480 T AT98940480 T AT 98940480T AT 98940480 T AT98940480 T AT 98940480T AT E237360 T1 ATE237360 T1 AT E237360T1
Authority
AT
Austria
Prior art keywords
relating
regulation
cell activation
subject
cell
Prior art date
Application number
AT98940480T
Other languages
English (en)
Inventor
Luis Alvarez-Vallina
Stephen James Russell
Robert Hawkins
Siamak Agha-Mohammadi
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9718872.6A external-priority patent/GB9718872D0/en
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of ATE237360T1 publication Critical patent/ATE237360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT98940480T 1997-09-06 1998-09-07 Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation ATE237360T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9718872.6A GB9718872D0 (en) 1997-09-06 1997-09-06 Improvements in or relating to expression of immunogenic substances
GBGB9723448.8A GB9723448D0 (en) 1997-09-06 1997-11-07 Improvements in or relating to expression of immunogenic substances
US7644898P 1998-03-02 1998-03-02
PCT/GB1998/002689 WO1999012573A1 (en) 1997-09-06 1998-09-07 Improvements in or relating to regulation of t cell activation

Publications (1)

Publication Number Publication Date
ATE237360T1 true ATE237360T1 (de) 2003-05-15

Family

ID=27269003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940480T ATE237360T1 (de) 1997-09-06 1998-09-07 Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation

Country Status (7)

Country Link
EP (2) EP1009442B1 (de)
JP (2) JP2001515873A (de)
AT (1) ATE237360T1 (de)
AU (2) AU747045B2 (de)
CA (2) CA2303618A1 (de)
DE (1) DE69813573T2 (de)
WO (2) WO1999012573A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589362A (en) * 1993-06-14 1996-12-31 Basf Aktiengesellschaft Tetracycline regulated transcriptional modulators with altered DNA binding specificities

Also Published As

Publication number Publication date
AU8992698A (en) 1999-03-29
AU747045B2 (en) 2002-05-09
AU8879998A (en) 1999-03-29
JP2001515709A (ja) 2001-09-25
CA2303617A1 (en) 1999-03-18
EP1009442A1 (de) 2000-06-21
JP2001515873A (ja) 2001-09-25
DE69813573D1 (de) 2003-05-22
EP1015036A1 (de) 2000-07-05
EP1009442B1 (de) 2003-04-16
DE69813573T2 (de) 2004-02-26
WO1999012574A1 (en) 1999-03-18
WO1999012573A1 (en) 1999-03-18
AU734877B2 (en) 2001-06-21
CA2303618A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
DK0559884T4 (da) Rekombinante virusvektorer til ekspression i muskelceller
DE69334257D1 (de) Methode zur Einführung von genetischem Material in Zellen
ES2185695T3 (es) Terapia genica dirigida.
DK371087D0 (da) Mamalialt interleukin-4
PL267473A1 (en) A transskin curative system and a method of its production
DE69022290T2 (de) Lebende Impfstoffe.
ATE69241T1 (de) Herstellung von polypeptiden mit humangammainterferon-aktivitaet.
ES2055686T3 (es) Procedimiento para preparar proteinas con factor de granulocitos-macrofagos "estimulador de colonias".
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ATE237360T1 (de) Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
ATE126275T1 (de) Expression in eukaryoten.
NO873437L (no) Human placenta angiogen faktor i stand til aa stimulere kapillaer endotelcelle-proteasesyntese, dna-syntese og migrasjon.
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
DE60032143D1 (de) Verwendung von eif4e-bindungsreagenzien in der therapie
AR242636A1 (es) Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos.
IT1152720B (it) La demarizzazione delle acque di vegetazione, il recupero dell'olivamarina e la produzione di concentrati e di farine deamarizzati naturali o fermentati, per alimentazione umana od animale
RU97102947A (ru) Способ лечения диффузного токсического зоба

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties